The activation of cholinergic pathways by nicotine elicits various physiological and pharmacological effects in mammals. For example, the stimulation of nicotinic acetylcholine receptors (nAChRs) leads to an antinociceptive effect.
Introduction
Damage to peripheral nerves triggered by surgery, an infection, or diabetes has been suggested to induce a tactile allodynia, which is a state of pain produced by innocuous stimuli. This painful sensation is often persistent, and very difficult to ameliorate because it is refractory to conventional treatments such as applications of anti-inflammatory drugs or opioids. Therefore, it is important to establish a therapeutic treatment for neuropathic pain. Nicotine has been shown to have various physiological and pharmacological effects such as the modulation of neurotransmission, neuroprotection, or differentiation through the activation of nicotinic acetylcholine receptors (nAChRs), which are pentameric ligand-gated ion channels composed of combinations of α (α2-α10) and β (β2-β4) subunits (Girod et al., 2000; Ryan et al., 2001; Arredondo et al., 2002) . It has been pointed out that nasal applications of nicotine are effective at inhibiting pain following surgery (Flood and Daniel, 2004) . In fact, it has been indicated that nicotine exerts antinociceptive effects in animal models of pain by interacting with one or more of the subtypes of nAChR which are present in the central or peripheral nerve system. For example, it has been suggested that the stimulation of peripheral nAChRs led to an antinociceptive effect on formalin-induced pain (Gilbert et al., 2001) . Furthermore, the intracerebroventricular administration of nicotine or nicotinic agonists produced a potent antinociceptive effect in models of acute pain (Rao et al., 1996; Wang et al., 2005) . The intrathecal administration of nicotine has been indicated to have an analgesic effect on nerve injury-evoked thermal and mechanical hyperalgesia via the stimulation of α4β2 nAChRs (Rashid and Ueda, 2002) . Although several studies have suggested antinociceptive actions of nicotine or nAChR agonists, it remains unclear whether stimulation of nAChRs at the spinal level has an antinociceptive effect on nerve injury-induced allodynia, and which subtypes of the receptor might be involved in the analgesic action of nicotine. Therefore, in the present study, we attempted to characterize the effects of nicotine or nicotinic agonists at the spinal level on mechanical allodynia in a model of neuropathic pain.
Several animal models of chronic neuropathic pain in which sciatic or spinal nerves are partially ligated have been established for research into pain therapeutics. It has been suggested that the differences in the time-course of the induction and maintenance of allodynia after surgery and the degree of pain triggered by thermal or mechanical stimuli might be in part dependent on the intensity or position of the ligation. For simplicity, here we selected a model in which the tibial branch of the sciatic nerve is transected; the tibial nerve transection (TNT) model (Lee et al., 2000; Hofmann et al., 2003) .
In this study, it was found that the intrathecal administration of nicotine had an antinociceptive effect on TNT-induced allodynia, which might involve stimulation of the α4β2 and α7 subtypes of nAChR at the spinal level. We further revealed that the glycinergic inhibitory system, but not the GABAergic inhibitory system, might contribute to the antinociceptive effect of nicotine on nerve injury-induced allodynia.
Methods

Surgery to transect the tibial nerve and drug administration
Male Wistar rats (200-300 g) were used in all experiments. The rats were housed at 22±2℃. All procedures and handling of the animals were performed according to both the Guiding Principles for the Care and Use of Laboratory Animals approved by the Japanese Pharmacological Society and the guidelines of Hiroshima University, Hiroshima, Japan. The TNT was performed as described previously (Lee et al., 2000; Hofmann et al., 2003) . Under anesthesia with sodium pentobarbital (50 mg/kg i.p.), the skin of the lateral surface of the right thigh was incised and the sciatic nerve and its three branches (the sural, common peroneal, and tibial nerves) were exposed. Then, the tibial nerve was transected just distal to the trifurcation of the sciatic nerve and furthermore, a 2-mm section of the transected nerve was cut to prevent rejoining. The other two nerves remained intact. The wound was closed by suturing first the muscle and then the skin. A sham-operation was also performed in which the tibial nerve was exposed but not transected. For intrathecal injections, rats were implanted with catheters according to the methods described by Yaksh et al. (1980) . A polyethylene tube (PE-10) was inserted into the subarachnoid space through a small incision, and the tip of the catheter was implanted close to the L4-L5 spinal segment and externalized through the skin. The volume of drug injected in all cases was 10 μl and a further 10 μl of saline was used to flush the catheter.
Measurement of mechanical allodynia
All behavioral tests to assess mechanical withdrawal threshold were conducted using a Dynamic planter aesthesiometer (Ugo Basile, Italy). Rats were placed inside acrylic cages on a wire mesh grid floor and allowed to acclimatize for a period of 30 min. The probe for the mechanical stimulus was then attached to the middle of the plantar surface of the right or left hindpaw. The pressure applied was automatically increased until the paw was withdrawn. Therefore, maximal accepted force was determined. The cut-off pressure was set at 30 g.
Drugs
Nicotine was purchased from Nacalai Tesque (Kyoto, Japan 
Statistical analysis
Data were expressed as the mean±S.E. Differences between groups were determined using a one-way analysis of variance with a pairwise comparison by the Bonferroni method. The criterion of significance was a P value less than 0.05.
Results
Intrathecal nicotine suppressed the TNT-induced allodynia in rats.
In an initial series of experiments, we found that the rats significantly developed mechanical allodynia on the ipsilateral side about 3 weeks after TNT, and this lasted for about 5 weeks (Fig. 1a) . There tended to be less allodynia on the contralateral side, but these responses were not significant. Sham-operated rats showed no apparent response to mechanical stimuli at any of the time points of measurement.
In the mechanical withdrawal threshold test, the effects of nicotine and several drugs on the mechanical allodynia were examined on days 20-35 post-surgery (Fig. 1b) . Although nicotine had no significant effect on the TNT-induced allodynia at 0.1 nmol, it produced significant antinociception from 10 to 40 minutes post-injection at 1 nmol. This antinociceptive effect gradually declined, with a return to the pre-injection level at 60 min. Similarly, 10 nmol of nicotine also elicited a significant antinociceptive effect, but it disappeared earlier than did the effect at 1 nmol. Therefore, we selected 1 nmol as the dose of nicotine for subsequent experiments.
Effects of several nAChR antagonists on the antiallodynic effect of nicotine.
To characterize which subtypes of nAChR might be involved in the antinociceptive effect of nicotine in the TNT model, we investigated the actions of various nAChR antagonists. In this study, all antagonists were administered intrathecally 10 minutes before the injection of nicotine. Saline was injected as the vehicle of each antagonist. Pretreatment with mecamylamine (1 nmol), a non-selective and non-competitive nicotinic antagonist, completely inhibited the antinociceptive effect of nicotine on TNT-induced mechanical allodynia (Fig. 2a) .
Similarly, DHβE, a selective α4β2 nAChR antagonist (10 nmol), also blocked the antiallodynic effect (Fig. 2b) . Furthermore, MLA, a selective α7 nAChR antagonist (10 nmol), had a less, but significant inhibitory effect on the antinociception induced by nicotine (Fig. 2c) . We confirmed that the injection of these antagonists alone had no effect on the mechanical allodynia triggered by TNT in the rats (data not shown).
Effects of RJR-2403, a selective α4β2 agonist, or choline, a selective α7 agonist, on the TNT-induced allodynia.
We next examined the effect of nAChR agonists on the TNT-induced mechanical allodynia. As shown in Fig. 3a , the intrathecal injection of 10 or 100 nmol of RJR-2403, which is relatively selective of α4β2 nAChRs (Papke et al., 2000) , significantly reversed the mechanical allodynia. It was found that 10 or 100 nmol of choline, which is known to act as a selective α7 agonist (Damaj et al., 2000; Wang et al., 2005) , also had an antiallodynic effect on the TNT-induced allodynia (Fig. 3b) . Furthermore, we observed that pretreatment with MLA ( Fig. 4a ), but not atropine (Fig. 4b) or DHβE (data not shown), significantly inhibited the antinociception induced by choline.
Involvement of the glycinergic inhibitory system in the nicotine-induced antiallodynic action in the TNT model.
To elucidate the underlying systems of the nAChR-mediated antiallodynic effect in the rats, we first examined the interaction of the glycinergic system in the nicotine-induced antinociception using a glycine receptor antagonist, strychnine ( Fig. 5a ). In both the sham-operated rats and the TNT model, the intrathecal injection of 10 nmol of strychnine alone had no significant influence on behavior compared with before the injection. Pretreatment with 10 nmol of strychnine completely blocked the nicotine-induced antiallodynic action in the transected rats. Furthermore, strychnine also significantly suppressed the antiallodynic effect of RJR-2403 or choline (Fig. 5b) . Next, we investigated the involvement of the GABAergic system in the antinociceptive effect of nicotine. However, intrathecal pretreatment with 10 nmol of bicuculline, which is a selective antagonist for the GABA A receptor, did not inhibit the nicotine-induced antinociception ( Fig. 6 ).
Discussion
We observed observed in other models of neuropathic pain (Nahin et al., 1994; Honore et al., 2000) . In this study, we found that on the side ipsilateral to the TNT, mechanical withdrawal threshold was markedly decreased compared with that in sham-operated rats. This sensation was induced about 3 weeks after the transection, and maintained for about 5 weeks. This observation is consistent with the finding that the mechanical allodynia in the TNT model was more robust and long-lasting than that in other models of peripheral nerve injury (Dowdall et al., 2005) .
It has been demonstrated that nAChR agonists have an analgesic effect on persistent formalin-induced pain, inflammation-induced mechanical and thermal hyperalgesia, or acute thermal pain such as hot plate and tail-flick pain (Lawand et al., 1999; Damaj et al., 1999 Damaj et al., , 2000 Wang et al., 2005) . In models of neuropathic pain, the intrathecal administration of nicotine has been indicated to have analgesic effects on both mechanical and thermal hyperalgesia via the stimulation of α4β2 nAChRs (Marubio et al., 1999; Rashid and Ueda, 2002) .
Furthermore, Bannon et al. (1998) have shown that the systemic administration of ABT-594, a potent α4β2 nAChR agonist, produced an analgesic effect in nerve injury-induced allodynia. However, it is not clear whether the intrathecal application of nicotine has antinociceptive effects on not only acute, inflammatory pain or hyperalgesia but also nerve injury-induced mechanical allodynia. As it is possible that the modulating systems of nociceptive transduction differ between the types of pain, it is important to investigate the effect of nicotine at the spinal level on mechanical allodynia in TNT models. In this study, we revealed that the intrathecal injection of nicotine significantly reversed TNT-induced mechanical allodynia with a maximal effect at 1 nmol.
Nicotine had no greater, and in fact a shorter, antinociceptive effect at 10 nmol than 1 nmol. It has been suggested that nicotine enhanced both inhibitory and excitatory transmission in the spinal dorsal horn (Genzen and McGehee, 2003; Cordero-Erausquin et al., 2004) . Therefore, the excitatory action triggered by a high dose of nicotine might reduce the inhibitory effect of nicotine in the spinal cord. Another possibility for the shorter effect of nicotine at 10 nmol could be due to the desensitization to the nicotine effect, because it is characteristic of nicotine to develop the stimulatory and the subsequent inhibitory action, especially at high doses.
Together, our results strongly support the involvement of both α4β2 and α7
nAChRs at the spinal level in the antinociceptive effects of nicotine on TNT-induced mechanical allodynia. It has been demonstrated that the α4β2 nAChR in the central nervous system is the most important receptor mediating nociceptive transduction (Marubio, et al., 1999; Rashid and Ueda, 2002) . The finding in the present study that the intrathecal delivery of RJR-2403, a selective agonist for the α4β2 nAChR, produced an antiallodynic effect similar to nicotine, and DHβE, a selective antagonist for the α4β2 nAChR, suppressed the nicotine-induced antiallodynic effect, also supports an important role for the α4β2 nAChR-mediated regulation of allodynia in nerve injury. DHβE also has antagonistic effects on the other types of nAChR, especially those including β2
subunit. However, DHβE acts about 100-times more sensitive to α4β2 than α7 nAChR (Chavez-Noriega et al., 1997) . On the other hand, the α7 nAChR has been indicated to be distributed extensively in the central nervous system and at peripheral sites and contribute to several functions such as the regulation of neuronal growth and differentiation or neuroprotection. However, the relationship between the α7 nAChR and nociception is largely unclear. Only recently, the administration of choline, a selective agonist for the α7 nAChR, was shown to elicit an antinociceptive effect in an acute pain model (Damaj et al., 2000) and in a formalin-induced inflammatory model (Wang et al., 2005) . On the other hand, some studies have suggested that the selective α7 antagonist MLA was unable to block nicotinic agonist-induced analgesia (Khan et al., 1998; Rashid and Ueda, 2002) . The present study demonstrated that the selective agonist for α7 nAChRs choline and antagonist for α7 nAChRs MLA, produced an antiallodynic effect and antagonized the antinociceptive effect of nicotine, respectively, although these effects were somewhat less potent than those of the agonist and antagonist for the α4β2 nAChR. Although choline is a full agonist of α7 nAChR, nAChRs. Moreover, the expression of TNF-α increases in DRG after nerve injury (Schäfers et al., 2002 (Schäfers et al., , 2003 . Since the upregulation of TNF-α production in both DRG and spinal cord is known to enhance the sensitivity of nociceptive perception, inhibition of the production or release of this cytokine through the stimulation of α7 nAChRs might lead to a decrease in the facilitation of pain. The possibility that these phenomena contribute to the antiallodynic action of nicotine via the activation of α7 nAChRs is of particular interest and should be investigated further. , 1998; Milne et al., 2001; Loomis et al., 2001) . In those studies, however, the dose of strychnine required to produce the allodynia was higher (about 10-fold) than that used in our study. Moreover, we confirmed that neither sham-treated nor transected rats treated with strychnine alone developed mechanical allodynia or motor dysfunction. Some studies showed that strychnine acts as a competitive antagonist of α7 nAChR (Seguela et al., 1993) .
Although the possibility can not be entirely ruled out that the antagonistic effect of strychnine on nicotinic agonists-induced antiallodynic effect might be due to the association of strychnine with α7 nAChR, we speculate that this possibility does not seem to hold true in this study for the following reasons. The affinity of strychnine to α7 nAChR is much lower than that to glycine receptors, for examples, Ki for strychnine as an inhibitor of the α7 nAChR and glycine receptors were found to be approximately 680 nM and 32 nM, respectively (Anand et al., 1993; Saitoh et al., 1994) . Moreover, the IC 50 for strychnine to block α4β2 nAChR-stimulated currents in hippocampal neurons was about 118
μM (Matsubayashi et al., 1998) . Thus, the affinities of strychnine for these receptors are considerably different. In our preliminary experiment, an injection of 30 nmol of strychnine produced the convulsions. Considering about 20-fold low affinity of strychnine to α7 nAChR than glycine receptor, more than convulsive dose of strychnine would be required to block α7 nAChR. Whereas, low dose of strychnine less than convusive dose almost completely blocked the effect of 100 nmol of choline. Together, the antagonistic action of strychnine in this study might be mainly due to the blockade of glycine receptors. On the other hand, we found that pretreatment with an intrathecal injection of bicuculline, a 
